版權說明:本文檔由用戶提供并上傳,收益歸屬內容提供方,若內容存在侵權,請進行舉報或認領
文檔簡介
1、最新Aekffyt中華醫(yī)學會系列雜志論文投送介紹信及授權書 投送期刊生命是永恒不斷的創(chuàng)造,因為在它內部蘊含著過剩的精力,它不斷流溢,越出時間和空間的界限,它不停地追求,以形形色色的自我表現(xiàn)的形式表現(xiàn)出來。泰戈爾 中華醫(yī)學會系列雜志論文投送介紹信及授權書 投送期刊: 雜志 稿件編號: 論文題目: 正式發(fā)表題目編輯部填寫: 主要內容及特殊要求: 基金工程請?zhí)峁徟陀〖?單位審查意見:經(jīng)核查,該論文不存在資料不真實、剽竊他人學術成果、一稿多投等學術不端行為以及其他與國家有關法律法規(guī)相違背的問題,同意向貴刊投稿。 負責人簽名: 單位蓋章 年 月 日 論文授權:如該論文被刊用,根據(jù)?中華人民共和國
2、著作權法?及其實施條例的有關規(guī)定,考慮到中華醫(yī)學會在該論文正式刊登前所付出的創(chuàng)造性勞動,作者同意自該論文正式發(fā)表之日起,將其著作權及相關財產(chǎn)權轉讓給中華醫(yī)學會。中華醫(yī)學會對該論文的局部或全文具有但不限于以下專有使用權:匯編權、發(fā)行權、復制權、翻譯權、網(wǎng)絡出版及在全世界范圍的信息傳播權;許可國內外文獻檢索系統(tǒng)和數(shù)據(jù)庫收錄并使用;允許以現(xiàn)有及未來出現(xiàn)的各種介質、媒體以及其他語言文字出版和使用;以不違反中華人民共和國現(xiàn)行和以后出臺的法律規(guī)定的方式使用。該論文發(fā)表后,中華醫(yī)學會向作者一次性酌致稿酬,該稿酬已含該論文著作權轉讓的費用。 論文作者承諾:1論文系作者請在方框中劃勾:原創(chuàng)性作品,翻譯作品,文獻
3、綜述作品;無知識產(chǎn)權糾紛,未一稿多投,不涉及任何形式之保密義務,未曾以所投期刊使用的語種公開發(fā)表。2未經(jīng)中華醫(yī)學會書面許可,不再以發(fā)表該論文期刊使用的語種、任何方式在全世界范圍發(fā)表此文或允許第三方使用該論文。 中華醫(yī)學會同意,從該論文發(fā)表之日起,作者享有其非專有使用權,行使該項權利時應得到中華醫(yī)學會的許可,但不得使用發(fā)表該論文期刊的版式。 中華醫(yī)學會和作者任何一方違反上述約定,按照?中華人民共和國著作權法?的有關規(guī)定,承當相應責任。關于作者其他權利的約定,可由作者提出,雙方協(xié)商確定。本授權書自論文發(fā)表之日起生效,有效期同該論文著作權的保護期。 假設該論文為職務作品,請作者予以說明,并由作者所在
4、單位與作者共同簽署本授權書。 論文全部作者親筆簽名請按作者排名順序填寫,姓名后附簽名日期: 1 2 3 4 5 6 7 8 9 10 11 12 通信 辦公 : : 地址: : Email: Covering letter and copyright transfer form for manuscripts submitted to Chinese Medical Association Journals Title of journal: Manuscript No.: Title of manuscript: Title of published articlefilled in by
5、editorial staff: Main content and specific requirements: Funding (copies of grant proposal approval necessary: Institutional approval or comments:This article has been approved to publish in the indicated journal for its originality and integrity without fraud such as fabrication, plagiarism, duplic
6、ate submission, or other issues running against the existing laws or regulations of the Peoples Republic of China. Signature of guarantor: Official Seal: Date: Authorization for the article: In consideration of the Copyright Law of the Peoples Republic of China and relevant regulations and the creat
7、ive contribution to the submitted material made by editors from the Chinese Medical Association (CMA) journals before publication, the author or authors agree to transfer their copyrights or relevant property rights to the CMA on the date of signing this transfer agreement if the article has been ac
8、cepted for publication by CMA journals. The CMA has the rights for, but not limited to compilation, publication, reproduction, interpretation, E-publication, and worldwide transmission of the article in whole or in part, while permitting to be included in, searched and used by retrieval systems such
9、 as Internet or databases in China and abroad, or to be published and used in other languages via different media existing or arising later in the way that is not against the existing law of the Peoples Republic of China or the law issued afterwards. The CMA will make a full payment including copyri
10、ght transfer fee to the author or authors after the article is published. The author or authors confirm that: (1) this writing is an original work (mark with a tick in the pane) ; a translation ; a review article . The article is free from intellectual property dispute, not a duplicate submission no
11、r confidential in any form; it has not been published in the language which CMA journals use. (2) The author or authors will not publish the article worldwide in any form or any media in the language which CMA journals use or permit a third party to use it without the permission from the CMA. The CM
12、A agrees that the author or authors have non-exclusive rights to use the article, but they have to get permission from the CMA before their exercise. However, using the format of CMA journals by which this article is published is forbidden. The CMA or the author or authors should bear the correspond
13、ing responsibilities if either of them infringes this agreement in accordance to the Copyright Law of the Peoples Republic of China. For the other rights of the author or authors, they should be put forward by the author or authors and negotiated by the two sides. This authorization takes effect from the date of the articles publication, and the period of validity should be as long as the copyright protection period of this article. If the article is a work creation, please make a note and sign the agreement by the institut
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內容里面會有圖紙預覽,若沒有圖紙預覽就沒有圖紙。
- 4. 未經(jīng)權益所有人同意不得將文件中的內容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內容本身不做任何修改或編輯,并不能對任何下載內容負責。
- 6. 下載文件中如有侵權或不適當內容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 腎病綜合癥的護理
- 元旦創(chuàng)意畫課件
- 詹天佑說課課件教學課件教學
- 護理不良事件事件分析
- 校長規(guī)劃學校發(fā)展大賽
- 學校面試自我介紹15篇
- 八年級下冊英語教學工作總結
- 經(jīng)理的上半年工作總結
- 監(jiān)控方案集合10篇
- 中學生演講稿3篇
- 大部分分校:地域文化形考任務三-國開(CQ)-國開期末復習資料
- 《大學生工匠精神及培養(yǎng)研究》
- 二零二四年物流園區(qū)建設合作協(xié)議
- 醫(yī)療機構輿情應急處置預案
- 中國計量大學《數(shù)據(jù)科學導論》2022-2023學年第一學期期末試卷
- 第六單元《平移、旋轉和軸對稱》-2024-2025學年三年級數(shù)學上冊單元測試卷(蘇教版)
- OECD -二十國集團 經(jīng)合組織公司治理原則2023
- 2024年廣東省深圳市33校聯(lián)考中考英語一模試卷
- 2024年全新初二生物上冊期末試卷及答案(人教版)
- 大學生心理健康與發(fā)展學習通超星期末考試答案章節(jié)答案2024年
- GB/T 10433-2024緊固件電弧螺柱焊用螺柱和瓷環(huán)
評論
0/150
提交評論